View from the Far Side

What is Sceletium Tortuosum (Kanna) and How Can It Benefit Anxiety, Depression, Addiction, and Insomnia?

Sceletium tortuosum, commonly known as Kanna, is a succulent plant indigenous to South Africa that has piqued the interest of botanists, medical professionals, and ethnobotanists for centuries. Its journey from traditional use by the San people to becoming the subject of modern clinical research encapsulates a fascinating intersection of botany, history, pharmacology, and potential therapeutic applications. This blog post delves into the various aspects of Sceletium tortuosum, exploring its botanical characteristics, historical significance, pharmacological properties, and its implications for treating conditions such as addiction, anxiety, and insomnia.


The Botany of Sceletium Tortuosum

Sceletium tortuosum belongs to the succulent family Mesembryanthemaceae (Aizoaceae). The genus name, Sceletium, is derived from the Latin word for skeleton, referencing the skeletonized appearance of the plant’s dried lower leaves. This plant is characterized by its ability to thrive in the semi-arid regions of South Africa, including the Northern Cape, Western Cape, and Eastern Cape provinces. It is one of approximately nine species within the genus, with some species complexes, particularly Sceletium tortuosum, being of significant interest due to their unique properties and uses.

Historical Reports and Significance of Sceletium Tortuosum

Sceletium tortuosum, commonly known as Kanna, has a rich historical tapestry that dates back several centuries, intertwining with the cultural and medicinal practices of indigenous South African communities. This section delves into the historical significance of Kanna, exploring its early records, cultural implications, and the evolving understanding of its uses from both indigenous and colonial perspectives.

Pre-History

Indigenous Origins & Traditional Use

The indigenous Khoikhoi and San people of Southern Africa are the first to discover the properties of Kanna. They chew, smoke, or use the fermented plant as a snuff for social and spiritual rituals, valuing it for its ability to relieve thirst, fight fatigue, and elevate mood. This traditional use predates all written history.

1610

First European Mention

The crew of a Dutch ship named The Globe, docking in what is now Saldanha Bay, near Cape Town, documents their search for a local root called โ€œKanna.โ€ The shipโ€™s logs compare its properties to Ginseng, a highly valued medicinal root in Asia, marking the first written European record of the plan

1685

Botanical Documentation

As part of a Dutch expedition to Namaqualand, artist and naturalist Heinrich Claudius creates detailed botanical illustrations of the local flora. His paintings include Sceletium tortuosum, providing the first scientific visual record and confirming its importance among the indigenous people

1726

Historical Differentiation

A Dutch Minister noted that the โ€œcanna of the hottentots [Khoikhoi]โ€ closely resembled the Chinese root nisi or ginseng, suggesting a separation of the two plants was beginning.

1851

Global Exhibition & Narcotic/Sedative Dichotomy

Sceletium tortuosum (using the name Mesembryanthemum tortuosum) was exhibited at the Great London Exhibition. This is considered the most important moment Kanna was exposed globally. German physician Pappe noted its narcotic properties but also its use by colonists as a “good sedative.”

Mid-to-Late 19th Century

San Ethnobotany: Bleek & Lloyd Archives

Wilhelm Bleek and Lucy Lloyd documented the San name !kwaiล„ (Kasinโ€™s entry), describing its use for ill breastfeeding children

1871-1875

US Export & Early Pharmacopoeia Listing

Sceletium was likely exported to the United States, appearing in two US Botanical Handbooks describing its properties as narcotic. (Narcotic in those days meant a sedative substance that relieves pain and produces sleep).

1995

Commercial Development, Partnership & Early Clinical Reports

Dr. Gericke’s fieldwork and ethnobotanical research began, following the historic Dutch expedition route and interviewing traditional healers including Gert Dirske, and Jap-Jap Klaasse) and shepherds including Lodewyk Mories.

Late 1990s

Commercial Development and Partnerships


Material from experimental cultivation (40 kg) was distributed to online companies (OM-Chi Herbs, Conscious Dreams, Botanical Art), making Kanna widely available to the entheogen and research communities

2000

Formation of the Collaborative Enterprise

The company Phyto Nova was founded by Dr. Gericke with two indigenous healers and two academics as partners to produce products from indigenous South African plants, including the commercialisation of the first tablets of Sceletium.

2001

First Clinical Case Reports

The first clinical case reports, focusing on the anxiolytic and antidepressant activity of Sceletium, were presented in Australia and published

Post-2010

Chemistry, Mechanisms of Action, & Zembrinยฎ Standardization

Screening of the extract (Zembrin) identified two key activities: Serotonin Reuptake Inhibition (SSRI/SRI, Prozac-like) and Phosphodiesterase IV (PDE4) inhibition.

2013-2017

Clinical Validation

The first ever clinical studies on Sceletium: Four foundational randomised, double-blind, placebo controlled pilot clinical studies, published in leading journals, demonstrated that Zembrinยฎ was safe taken daily for three months, had anti-anxiety potential in fMRI brain-imaging study, had pro-cognitive effects, and a significant reduction in the HAMA-A anxiety score at a 50 mg dose taken daily for six weeks.

Chemistry and Treatment Modalities
The chemistry of Sceletium tortuosum is complex, with its psychoactive properties attributed to a range of alkaloids, including mesembrine, mesembrenone, and mesembrenol. These compounds interact with the brainโ€™s serotonin system, offering a potential mechanism for its effects on mood and cognition, in addition these compounds have PDE4 inhibitory activity, an additional mechanism for their anti-anxiety, antidepressant and pro-cognitive activities. Treatment modalities utilizing Sceletium tortuosum, such as the standardized extract Zembrinยฎ, are being explored for their safety, efficacy, and optimal dosing in clinical settings.

.


Early Documentation and Cultural Integration

The earliest documented mention of Kanna dates back to 1610 when a ship named The Globe, captained by Captain Hipon, docked in Cape Town Harbor. The ship’s logs recorded diligent searches for a root known locally as Kanna, which was likened to Ginseng for its properties. This comparison to Ginseng, a well-regarded medicinal root in Japanese culture, highlights the early recognition of Kanna’s potential medicinal value. The logs specify that the root was sought after during December, January, and February, indicating knowledge of the optimal times for harvesting the plant.

Indigenous Use and European Observation

The use of Kanna was not limited to medicinal purposes; it also held significant cultural value among the indigenous Khoikhoi and San people. These communities used Kanna in various traditional rituals, which were observed and sometimes misunderstood by European colonizers. For instance, the Dutch expeditions in the late 17th century, particularly the one led in 1685 to Namaqualand, documented the use of Kanna.

The expedition’s artist, Heinrich Claudius, painted detailed illustrations of the flora encountered, including Sceletium tortuosum, confirming its use and importance among the indigenous people. The Dutch noted that the indigenous people used Kanna for its intoxicating effects, a practice that was often viewed through a colonial lens that did not fully appreciate the cultural and social contexts of its use. This period marked the beginning of a dichotomy in the perception of Kanna: while indigenous people valued it for both its physical and spiritual healing properties, European colonizers focused more on its potential economic and medicinal exploitation.

Trade and Cultural Misunderstandings

The trade of Kanna also featured in historical records, with mentions of its exchange between local tribes and European traders. The confusion between Kanna and Ginseng persisted into the 19th century, as evidenced by various European texts mistaking Kanna for a type of Ginseng. This confusion underscores the challenges of cross-cultural exchanges and the misinterpretation of indigenous knowledge by European traders and explorers.

Ethnobotanical Research and Modern Recognition

The significance of Kanna extended into modern times through ethnobotanical research, which sought to bridge traditional indigenous knowledge with contemporary scientific understanding. Researchers like Dr. Nigel Gericke played a pivotal role in this, exploring the ethnobotanical landscape of South Africa and documenting the ongoing use of Kanna by traditional healers. This research has helped to validate the historical and cultural importance of Kanna, providing a scientific basis for its traditional uses and integrating this knowledge into modern botanical and medical studies.

Pharmacology and Clinical Research

The pharmacological interest in Sceletium tortuosum centers around its active alkaloids, particularly mesembrine, which contribute to its psychoactive effects. These compounds have been shown to possess serotonin-uptake inhibitory properties, making them of interest for their potential therapeutic applications in treating mood disorders. Clinical research has begun to explore these possibilities, with studies investigating the standardized extract of Sceletium tortuosum, known as Zembrin, for its efficacy in improving cognitive function and reducing anxiety and stress.

Addiction Potential and Therapeutic Applications

One of the critical considerations in the study of Sceletium tortuosum is its addiction potential. Historical and ethnobotanical evidence suggests that the plant is used in low doses for well-being by indigenous communities, with no apparent dependence or addiction issues reported. This aspect is crucial for its potential therapeutic applications, as it suggests that Sceletium tortuosum could offer benefits without the risk of addiction commonly associated with other psychoactive substances.

The therapeutic applications of Sceletium tortuosum are diverse, ranging from its use in treating alcoholism and anxiety to its potential benefits for insomnia and general well-being. Traditional healers have used the plant to treat alcoholics, with anecdotal evidence suggesting its efficacy in reducing cravings and withdrawal symptoms. Additionally, its calming effects have been leveraged to alleviate anxiety and improve sleep quality, making it a subject of interest for further clinical research in these areas.

Chemistry and Treatment Modalities

The chemistry of Sceletium tortuosum is complex, with its psychoactive properties attributed to a range of alkaloids, including mesembrine, mesembrenone, and mesembrenol. These compounds interact with the brain’s serotonin system, offering a potential mechanism for its effects on mood and cognition. Treatment modalities utilizing Sceletium tortuosum, such as the standardized extract Zembrin, are being explored for their safety, efficacy, and optimal dosing in clinical settings.

Conclusion

Sceletium tortuosum represents a bridge between traditional knowledge and modern scientific inquiry, offering promising avenues for research and therapeutic applications. Its rich botanical, historical, and pharmacological background underscores the importance of integrating traditional practices with contemporary clinical research. As studies continue to unravel the complexities of this plant, the potential for Sceletium tortuosum to contribute to the fields of psychiatry, neurology, and holistic well-being remains vast and largely untapped.


FAQ

  1. 1. What is Sceletium tortuosum?

    Sceletium tortuosum, commonly known as Kanna, is a succulent plant from the Aizoaceae family, indigenous to the semi-arid regions of South Africa. It has a long history of traditional use and is now the subject of modern clinical research for its potential therapeutic benefits.

  2. 2. Where does the name “Sceletium” come from?

    The genus nameย Sceletiumย is derived from the Latin word for skeleton. This name refers to the skeleton-like appearance of the plant’s dried lower leaves.

  3. 3. What is the earliest known documentation of Kanna?

    The earliest documented mention of Kanna dates back to 1610. The logs of a ship named The Globe, captained by Captain Hippon in Cape Town Harbor, recorded searches for a root called Kanna, which was compared to Ginseng for its medicinal properties.

  4. 4. Which indigenous groups traditionally used Kanna?

    Kanna held significant cultural and medicinal value for the indigenous Khoikhoi and San people of South Africa, who used it in various traditional rituals.

  5. 5. What are the active chemical compounds in Sceletium tortuosum?

    The plant’s psychoactive properties are attributed to a range of alkaloids, most notably mesembrine, mesembrenone, and mesembrenol. These compounds are believed to interact with the brain’s serotonin system.

  6. 6. What are the potential therapeutic applications of Kanna?

    The text highlights several potential applications, including the treatment of addiction (specifically alcoholism), anxiety, stress, depression and insomnia. Traditional healers have used it to reduce cravings and withdrawal symptoms, while its calming effects may help alleviate anxiety and improve sleep.

  7. 7. Does Sceletium tortuosum have addiction potential?

    According to historical and ethnobotanical evidence mentioned in the article, indigenous communities used the plant in low doses for well-being with no apparent reports of dependence or addiction. This suggests it may offer benefits without the addiction risk associated with other psychoactive substances.

  8. 8. What is Zembrin?

    Zembrin is the first standardized and clinically studied extract ofย Sceletium tortuosum. It is being studied in clinical research for its effectiveness in improving cognitive function and reducing anxiety and stress.


RELATED CONTENT

Latest posts

View All